Annovis Bio
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Annovis Bio and other ETFs, options, and stocks.About ANVS
Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs aiming to treat neurodegenerative diseases, such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases.
ANVS Key Statistics
Stock Snapshot
With a market cap of 65.23M, Annovis Bio(ANVS) trades at $2.40. The stock has a price-to-earnings ratio of -1.64.
As of 2026-02-13, Annovis Bio(ANVS) stock has fluctuated between $2.37 and $2.55. The current price stands at $2.40, placing the stock +1.3% above today's low and -5.9% off the high.
The Annovis Bio(ANVS)'s current trading volume is 124.47K, compared to an average daily volume of 371.74K.
During the past year, Annovis Bio(ANVS) stock moved between $1.11 at its lowest and $5.50 at its peak.
During the past year, Annovis Bio(ANVS) stock moved between $1.11 at its lowest and $5.50 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.